Drugs Used in TB and Leprosy

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

1 Citation (Scopus)

Abstract

Multidrug resistance continues to be a problem in the treatment of tuberculosis (TB). With more cases of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), clinicians are reverting to second-line and third-line agents, which have proven to be more toxic in nature and costly. This chapter reviews the 2016 data on the side effect profiles of commonly used medications in Mycobacterium tuberculosis and Mycobacterium leprae infections. Medications covered in this chapter include bedaquiline, capreomycin, clofazamine, cycloserine, dapsone, delamanid, ethambutol, gatifloxacin, isoniazid, kanamycin, levofloxacin, moxifloxacin, pyrazinamide, and the rifamycins.

Original languageEnglish
Title of host publicationSide Effects of Drugs Annual
PublisherElsevier B.V.
Pages283-293
Number of pages11
DOIs
StatePublished - 1 Jan 2017

Publication series

NameSide Effects of Drugs Annual
Volume39
ISSN (Print)0378-6080

Fingerprint

bedaquiline
Capreomycin
Rifamycins
Cycloserine
Pyrazinamide
Dapsone
Ethambutol
Levofloxacin
Kanamycin
Poisons
Isoniazid
Leprosy
Tuberculosis
Extensively Drug-Resistant Tuberculosis
Mycobacterium leprae
Multidrug-Resistant Tuberculosis
Mycobacterium Infections
Multiple Drug Resistance
Mycobacterium tuberculosis
Pharmaceutical Preparations

Keywords

  • Adverse effects
  • Ethambutol
  • Isoniazid
  • Leprosy
  • Pyrazinamide
  • Rifamycins
  • Side effects
  • Tuberculosis

Cite this

Ramanathan, M. R., & Sanders, J. M. (2017). Drugs Used in TB and Leprosy. In Side Effects of Drugs Annual (pp. 283-293). (Side Effects of Drugs Annual; Vol. 39). Elsevier B.V.. https://doi.org/10.1016/bs.seda.2017.06.025
Ramanathan, Meenakshi Ravindran ; Sanders, James M. / Drugs Used in TB and Leprosy. Side Effects of Drugs Annual. Elsevier B.V., 2017. pp. 283-293 (Side Effects of Drugs Annual).
@inbook{22a0efdc794e450384d19f3ef6a2f871,
title = "Drugs Used in TB and Leprosy",
abstract = "Multidrug resistance continues to be a problem in the treatment of tuberculosis (TB). With more cases of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), clinicians are reverting to second-line and third-line agents, which have proven to be more toxic in nature and costly. This chapter reviews the 2016 data on the side effect profiles of commonly used medications in Mycobacterium tuberculosis and Mycobacterium leprae infections. Medications covered in this chapter include bedaquiline, capreomycin, clofazamine, cycloserine, dapsone, delamanid, ethambutol, gatifloxacin, isoniazid, kanamycin, levofloxacin, moxifloxacin, pyrazinamide, and the rifamycins.",
keywords = "Adverse effects, Ethambutol, Isoniazid, Leprosy, Pyrazinamide, Rifamycins, Side effects, Tuberculosis",
author = "Ramanathan, {Meenakshi Ravindran} and Sanders, {James M.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/bs.seda.2017.06.025",
language = "English",
series = "Side Effects of Drugs Annual",
publisher = "Elsevier B.V.",
pages = "283--293",
booktitle = "Side Effects of Drugs Annual",

}

Ramanathan, MR & Sanders, JM 2017, Drugs Used in TB and Leprosy. in Side Effects of Drugs Annual. Side Effects of Drugs Annual, vol. 39, Elsevier B.V., pp. 283-293. https://doi.org/10.1016/bs.seda.2017.06.025

Drugs Used in TB and Leprosy. / Ramanathan, Meenakshi Ravindran; Sanders, James M.

Side Effects of Drugs Annual. Elsevier B.V., 2017. p. 283-293 (Side Effects of Drugs Annual; Vol. 39).

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

TY - CHAP

T1 - Drugs Used in TB and Leprosy

AU - Ramanathan, Meenakshi Ravindran

AU - Sanders, James M.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Multidrug resistance continues to be a problem in the treatment of tuberculosis (TB). With more cases of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), clinicians are reverting to second-line and third-line agents, which have proven to be more toxic in nature and costly. This chapter reviews the 2016 data on the side effect profiles of commonly used medications in Mycobacterium tuberculosis and Mycobacterium leprae infections. Medications covered in this chapter include bedaquiline, capreomycin, clofazamine, cycloserine, dapsone, delamanid, ethambutol, gatifloxacin, isoniazid, kanamycin, levofloxacin, moxifloxacin, pyrazinamide, and the rifamycins.

AB - Multidrug resistance continues to be a problem in the treatment of tuberculosis (TB). With more cases of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), clinicians are reverting to second-line and third-line agents, which have proven to be more toxic in nature and costly. This chapter reviews the 2016 data on the side effect profiles of commonly used medications in Mycobacterium tuberculosis and Mycobacterium leprae infections. Medications covered in this chapter include bedaquiline, capreomycin, clofazamine, cycloserine, dapsone, delamanid, ethambutol, gatifloxacin, isoniazid, kanamycin, levofloxacin, moxifloxacin, pyrazinamide, and the rifamycins.

KW - Adverse effects

KW - Ethambutol

KW - Isoniazid

KW - Leprosy

KW - Pyrazinamide

KW - Rifamycins

KW - Side effects

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85026301102&partnerID=8YFLogxK

U2 - 10.1016/bs.seda.2017.06.025

DO - 10.1016/bs.seda.2017.06.025

M3 - Chapter

T3 - Side Effects of Drugs Annual

SP - 283

EP - 293

BT - Side Effects of Drugs Annual

PB - Elsevier B.V.

ER -

Ramanathan MR, Sanders JM. Drugs Used in TB and Leprosy. In Side Effects of Drugs Annual. Elsevier B.V. 2017. p. 283-293. (Side Effects of Drugs Annual). https://doi.org/10.1016/bs.seda.2017.06.025